MedCity News September 27, 2023
Evvy’s $14 million funding round was led by Left Lane Capital and included participation from General Catalyst, LabCorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue and Amboy Street Ventures. In total, Evvy has raised $19 million.
Evvy, a women’s health startup, closed its $14 million Series A funding round, which it will use to scale its vaginal health testing and care platform, the company announced Wednesday.
New York City-based Evvy is a direct-to-consumer company that launched in 2020 and offers a CLIA-validated at-home vaginal microbiome test. It checks for bacteria and fungi (or microbes) in people’s vaginas. It leverages metagenomic sequencing, which allows for an analysis of the entire genome. After taking the test, consumers receive a...
Today's Sponsors
Today's Sponsor